national stem-cell therapy logo

Tract Bio Unveils Key to CF Lung Inflammation

Tract Bio Logo

Tract Bio, a biotechnology company focused on developing therapies for cancer and inflammatory diseases, has recently announced a significant publication in the American Journal of Respiratory and Critical Care Medicine. The publication details their research on stem cell variants that contribute to chronic lung inflammation in cystic fibrosis patients treated with CFTR modulators. Key Highlights […]